Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.22
+0.10 (1.63%)
Nov 21, 2024, 1:56 PM EST - Market open
Lexeo Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$22.71
Upside
+265.11%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $23 | Strong Buy | Maintains | $21 → $23 | +269.77% | Nov 14, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $23 → $25 | Strong Buy | Maintains | $23 → $25 | +301.93% | Nov 13, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +205.47% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +237.62% | Oct 31, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +269.77% | Oct 30, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +269.77% | Oct 25, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +269.77% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +237.62% | Aug 13, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $24 | Buy | Reiterates | $24 | +285.85% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +253.70% | Jul 16, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +269.77% | Jul 15, 2024 |
| Baird | Baird | Buy Initiates $28 | Buy | Initiates | $28 | +350.16% | Jun 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +253.70% | Jun 6, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $22 → $24 | Buy | Maintains | $22 → $24 | +285.85% | Mar 12, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +269.77% | Nov 28, 2023 |
| Leerink Partners | Leerink Partners | Buy Initiates $19 | Buy | Initiates | $19 | +205.47% | Nov 28, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.